Gardner Named to Biotech Panel

Chris Gardner, the co-founder and CEO of Sequence Bio, a Newfoundland and Labrador genomic data company, has been appointed to the newly created federal Health/Bio-sciences Economic Strategy Table.
“Canadians are known for finding the better, smarter way - and it’s time we brought that thinking to health care,” Gardner said in a statement. “I’m proud to join this team of disruptors to drive